-- db/049_drugcentral_ddi.sql
-- =============================================================================
-- DrugCentral's `ddi` table as drugref's third interaction candidate source.
-- Design: docs/superpowers/specs/2026-08-23-drugref-drugcentral-ddi-ingest-design.md
-- Measurement it rests on:
--   docs/superpowers/specs/2026-08-23-drugref-drugcentral-ddi-remeasurement-results.md
--
-- RULE 6 IN ONE LINE: only `ddi_ref_id = 2` (VHA NDF-RT, a US federal work) is
-- ingested. `1` is Stockley's Drug Interactions (a copyrighted book) and `3` is
-- Lexicomp Online (a commercial compendium); both are permanently out, and
-- DrugCentral's own CC BY-SA 4.0 on the compilation is not evidence of a right to
-- relicense a third-party compendium inside it. The orchestrator additionally
-- verifies the dump's `reference` row identity before admitting a row, because `2`
-- is a surrogate key and a re-publication is free to renumber it.
-- =============================================================================

-- ============================================================================
-- 1. The source vocabulary -- two CHECKs and one Python table, in one commit
-- ============================================================================
-- COPIED VERBATIM from the live catalog and then extended by one value, never
-- retyped from a document. db/039's comment records the reason: a plan's stale
-- list still said ('MED-RT','MeSH') and would have DROPPED 'DRUGREF'.
--
-- src/drugref/ids.py gains "DRUGCENTRAL": "DRUGCENTRAL" in the same commit, and
-- src/drugref/provenance.py gains 'drugcentral_run'. The three are a TRIO: the
-- failure mode when one lands without the others is silent -- ids.canonical_source
-- would fold the source to a spelling this CHECK does not admit, and a per-source
-- rebuild would delete nothing and report success.
ALTER TABLE drugref.ingest_run DROP CONSTRAINT IF EXISTS ingest_run_source;
ALTER TABLE drugref.ingest_run ADD CONSTRAINT ingest_run_source
    CHECK (source IN ('UNII', 'CHEBI', 'MED-RT', 'MeSH', 'PBS', 'DRUGREF', 'GSRS',
                      'ONCHIGH', 'FDA-CYP', 'DRUGCENTRAL'));

ALTER TABLE drugref.ingest_run DROP CONSTRAINT IF EXISTS ingest_run_writer;
ALTER TABLE drugref.ingest_run ADD CONSTRAINT ingest_run_writer
    CHECK (writer IN ('unii_run', 'chebi', 'medrt_run', 'mesh_run', 'mesh_rel_run',
                      'pbs_run', 'curation', 'unattributed', 'gsrs_run',
                      'onchigh_run', 'fda_cyp_run', 'drugcentral_run'));

-- NOTE what is deliberately NOT widened, because a state file said otherwise:
-- class_contraindication_source stays ('MED-RT','ONCHIGH') and
-- moiety_contraindication_source stays ('MED-RT'). DrugCentral writes no class
-- rule and no row into either table -- its assertions are unordered moiety pairs
-- with a severity, which is neither shape.

-- ============================================================================
-- 2. ddi_source_severity -- an upstream band mapped to a drugref grade, AS DATA
-- ============================================================================
-- WHY A TABLE AND NOT FOUR LINES OF PYTHON. db/006's finding, one tier up: a
-- vocabulary written in code and in a CHECK is two lists to widen and one way to
-- disagree. And this mapping is additionally a CLINICAL JUDGEMENT that drugref
-- makes on a consumer's behalf -- a node operator must be able to SELECT it,
-- disagree with it, and see exactly what it did. Revising it is then a migration
-- over two rows rather than a re-ingest of 7,571.
--
-- THE MAPPING. VA/NDF-RT's own wording is "Critical = avoid the combination" and
-- "Significant = may have clinical consequences; monitor or adjust", so each band
-- maps to the drugref grade that says the same thing.
--
-- `major` CARRIES NO DRUGCENTRAL ROW, and that is a signal rather than an
-- omission: a two-band authority has two bands. The cost is stated rather than
-- hidden -- some `Significant` pairs (fluvoxamine + tapentadol, apixaban +
-- heparin) are arguably major and are graded a notch low. That is what the
-- curated overlay exists to correct, one pair at a time, and it is why this
-- mapping's revisability is load-bearing.
CREATE TABLE IF NOT EXISTS drugref.ddi_source_severity (
    source       text NOT NULL,
    source_label text NOT NULL,
    -- db/035's four grades and THEIR CLINICAL ORDER. A foreign key, not a CHECK:
    -- severity_rank is what decides which of two disagreeing grades a consumer
    -- sees, and a level with no agreed rank would make that non-deterministic.
    severity     text NOT NULL REFERENCES drugref.severity_kind(severity),
    -- Keyed PER SOURCE, because two authorities may both use the word
    -- 'Significant' and mean different things by it.
    PRIMARY KEY (source, source_label)
);

INSERT INTO drugref.ddi_source_severity (source, source_label, severity) VALUES
    ('DRUGCENTRAL', 'Critical',    'contraindicated'),
    ('DRUGCENTRAL', 'Significant', 'moderate')
ON CONFLICT (source, source_label) DO NOTHING;

COMMENT ON TABLE drugref.ddi_source_severity IS
    'How one upstream authority''s severity vocabulary maps onto drugref''s four '
    'grades. SEEDED, NOT CURATED: a new mapping is a migration, deliberately, '
    'because the mapping is a clinical judgement drugref makes on a consumer''s '
    'behalf and it must be inspectable by anyone who can run a query. The '
    'candidate tier stores the upstream label VERBATIM (drugcentral_ddi_assertion.'
    'severity_label) and derives the grade through this table, so the authority''s '
    'own words survive and drugref''s reading of them is separately visible.';
COMMENT ON COLUMN drugref.ddi_source_severity.source_label IS
    'The upstream string EXACTLY as published -- ''Critical'', not ''critical''. '
    'Folding it here would put a case rule in a second place.';

-- ============================================================================
-- 3. drugcentral_ddi_assertion -- every bundleable row, exactly as published
-- ============================================================================
-- A rebuildable projection keyed by ingest_run.source: delete-and-rebuild, like
-- every other ingested feed. The shape is db/039's fda_cyp_assertion, whose
-- comment states the principle -- "it holds every tuple the parser produced,
-- members and withheld alike, because the withheld ones are the point". Here the
-- withheld ones are the 37 rows whose endpoint drugref cannot key, and holding
-- them is what lets section 5's gap view exist without a table of its own.
CREATE TABLE IF NOT EXISTS drugref.drugcentral_ddi_assertion (
    ingest_run      bigint NOT NULL REFERENCES drugref.ingest_run(ingest_run_id),
    -- Symmetric with class_contraindication.source and every other projection's:
    -- widened per source as authorities land, not left open.
    source          text   NOT NULL
        CONSTRAINT drugcentral_ddi_assertion_source CHECK (source = 'DRUGCENTRAL'),
    -- DrugCentral's `ddi.source_id` -- the VA's OWN key for the interaction record
    -- ('C56^4966^'), NOT `ddi.id`. Measured 2026-08-23: all 7,571 bundleable rows
    -- carry a distinct source_id, so it is a valid key -- and it is the upstream
    -- AUTHORITY's identifier rather than an artifact of one dump's row numbering,
    -- which is what a key anything downstream might cite has to be.
    upstream_key    text   NOT NULL,
    -- The two endpoints AS THE DUMP GIVES THEM (`drug_class1`, `drug_class2`).
    -- Verbatim, never folded: fold_name is the resolver's rule and belongs in one
    -- place. The names are stored even when they resolved, because a name that
    -- STOPS resolving in a later release is only diagnosable against the name the
    -- earlier run actually read.
    endpoint_1_name text   NOT NULL,
    endpoint_2_name text   NOT NULL,
    -- `ddi.description`. MEASURED 2026-08-23: all 7,571 match
    -- 'NAME1/NAME2 [VA Drug Interaction]' -- 35 to 75 characters, no clinical
    -- content whatsoever, so issue 101's "every row carries a description" is true
    -- and empty. It is stored anyway for one reason: it names the endpoints at
    -- PRODUCT/SALT grain ('PIOGLITAZONE HCL', 'INDINAVIR SULFATE') while the
    -- endpoint columns carry the base, and that is the only visible explanation
    -- for why 33 pairs appear twice (see the view in section 4).
    upstream_label  text   NOT NULL,
    -- `ddi_risk`, VERBATIM -- 'Critical' or 'Significant' in this subset. drugref's
    -- own grade is DERIVED through ddi_source_severity, never stored here, so the
    -- authority's own words and drugref's reading of them stay separately visible.
    severity_label  text   NOT NULL,
    -- NULLABLE, and that is the whole design of this table. An endpoint drugref
    -- cannot key leaves the row here with a NULL uuid and a route saying why.
    moiety_1_uuid   uuid   REFERENCES drugref.substance_moiety(moiety_uuid),
    moiety_2_uuid   uuid   REFERENCES drugref.substance_moiety(moiety_uuid),
    -- HOW each endpoint resolved, or why it did not. The vocabulary is
    -- drugcentral_resolve.ROUTES and this CHECK is its SECOND home -- admitted
    -- deliberately and pinned by test_the_route_checks_match_the_python_vocabulary,
    -- on the same terms ids._SOURCE_CANONICAL and ingest_run_source already live
    -- under. `missing_keys_row` is in the list on purpose: it means a struct_id was
    -- found by name and is absent from the key index, which cannot happen on a
    -- well-formed extract -- counted apart so a corrupt extract does not pass for a
    -- difficult one.
    route_1         text   NOT NULL,
    route_2         text   NOT NULL,
    PRIMARY KEY (ingest_run, source, upstream_key),
    -- THE LOAD-BEARING CONSTRAINT. A release inventing a third band is refused at
    -- INSERT, loudly, rather than stored and silently mapped to nothing by the
    -- view's join. db/006's lesson applied to a vocabulary that crosses a source
    -- boundary.
    CONSTRAINT drugcentral_ddi_assertion_severity
        FOREIGN KEY (source, severity_label)
        REFERENCES drugref.ddi_source_severity(source, source_label),
    CONSTRAINT drugcentral_ddi_assertion_route_1 CHECK (route_1 IN
        ('display_name', 'inchikey', 'cas',
         'not_a_substance', 'no_structural_key', 'missing_keys_row', 'unresolved')),
    CONSTRAINT drugcentral_ddi_assertion_route_2 CHECK (route_2 IN
        ('display_name', 'inchikey', 'cas',
         'not_a_substance', 'no_structural_key', 'missing_keys_row', 'unresolved')),
    -- ONE CHECK PER ENDPOINT, not two nullable columns nobody cross-checks --
    -- curated_interaction_ruling_is_complete's shape. "Resolved but no uuid" and
    -- "a uuid on an unresolved route" are both UNREPRESENTABLE rather than merely
    -- discouraged.
    CONSTRAINT drugcentral_ddi_assertion_endpoint_1_complete
        CHECK ((route_1 IN ('display_name', 'inchikey', 'cas'))
               = (moiety_1_uuid IS NOT NULL)),
    CONSTRAINT drugcentral_ddi_assertion_endpoint_2_complete
        CHECK ((route_2 IN ('display_name', 'inchikey', 'cas'))
               = (moiety_2_uuid IS NOT NULL))
    -- NO SELF-PAIR CHECK, and the asymmetry with db/014's
    -- moiety_contraindication_not_self is deliberate. There a self-pair is a
    -- malformed assertion; here it is a CONSEQUENCE OF RESOLUTION -- two endpoint
    -- names legitimately folding onto one moiety -- so refusing it would abort an
    -- ingest over a correct reading of the source. The view in section 4 excludes
    -- it and the orchestrator's summary counts it as its own bucket, so it cannot
    -- become nonzero unnoticed. Measured 2026-08-23: 0 of 7,571.
);

CREATE INDEX IF NOT EXISTS drugcentral_ddi_assertion_by_moiety_1
    ON drugref.drugcentral_ddi_assertion (moiety_1_uuid);
CREATE INDEX IF NOT EXISTS drugcentral_ddi_assertion_by_moiety_2
    ON drugref.drugcentral_ddi_assertion (moiety_2_uuid);

COMMENT ON TABLE drugref.drugcentral_ddi_assertion IS
    'DrugCentral''s `ddi` table, `ddi_ref_id = 2` only (VHA NDF-RT), one row per '
    'published assertion. A REBUILDABLE PROJECTION, CANDIDATE TIER -- the 2023 '
    'release does not refresh, so rows feed review and must not auto-alert. '
    'UNORDERED: endpoint_1 and endpoint_2 are NOT subject and object. Measured '
    '2026-08-23, no ordered endpoint pair repeats and 33 appear in BOTH orders, '
    'so this source asserts no direction -- read drugcentral_ddi_pair, which '
    'canonicalises, rather than either endpoint column alone.';
COMMENT ON COLUMN drugref.drugcentral_ddi_assertion.severity_label IS
    'The upstream band VERBATIM. drugref''s grade is ddi_source_severity''s job.';

-- ============================================================================
-- 4. drugcentral_ddi_pair -- canonical unordered pairs, graded
-- ============================================================================
-- THREE RULES LIVE HERE AND NOWHERE ELSE, which is why this is a view and not
-- something the writer decided:
--
--  (a) ORIENTATION IS COLLAPSED. least/greatest gives one row per unordered pair.
--      The source publishes 33 pairs in both orders -- two VA entries at different
--      salt grains, visible in upstream_label -- and they are one pair.
--  (b) MOST-SEVERE-WINS between two orientations that disagree (4 of the 33 do).
--      `ORDER BY severity_rank` needs no DESC because db/035 made rank 1 the most
--      severe precisely so the safe read is the one a caller writes by default.
--  (c) A TOTAL ORDER, so (b) is REPRODUCIBLE. 29 of the 33 duplicates carry the
--      same band, so severity_rank ties and DISTINCT ON would otherwise keep
--      whichever row the plan emitted first -- and the reported upstream_key and
--      upstream_label could then differ between two runs over the same bytes.
--      That is exactly the defect found in three unordered registry lookups in the
--      round whose entire justification was reproducibility. upstream_key is a
--      primary-key component, so it breaks every tie.
--
-- db/037's standing instruction: the rule that chooses between two grades is
-- stated ONCE, in SQL, so a consumer querying from any language gets it.
CREATE OR REPLACE VIEW drugref.drugcentral_ddi_pair AS
SELECT DISTINCT ON (p.moiety_lo, p.moiety_hi)
       p.moiety_lo,
       p.moiety_hi,
       p.source               AS candidate_source,
       m.severity,                              -- drugref's grade, DERIVED
       s.severity_rank,
       p.severity_label       AS upstream_severity_label,  -- the authority's word
       p.upstream_key,
       p.upstream_label,
       p.ingest_run,
       r.upstream_release,                      -- WHICH release said so
       r.finished_at          AS ingested_at
FROM  (SELECT least(a.moiety_1_uuid, a.moiety_2_uuid)    AS moiety_lo,
              greatest(a.moiety_1_uuid, a.moiety_2_uuid) AS moiety_hi,
              a.*
         FROM drugref.drugcentral_ddi_assertion a
              -- Unresolved endpoints stay in the table and out of the pairs. They
              -- are gap_unresolved_ddi_endpoint's subject, not a consumer's.
        WHERE a.moiety_1_uuid IS NOT NULL
          AND a.moiety_2_uuid IS NOT NULL
              -- A rule whose two endpoints denote one substance asserts nothing
              -- about an interaction between two drugs.
          AND a.moiety_1_uuid <> a.moiety_2_uuid) p
JOIN  drugref.ddi_source_severity m
      ON m.source = p.source AND m.source_label = p.severity_label
JOIN  drugref.severity_kind s ON s.severity = m.severity
JOIN  drugref.ingest_run    r ON r.ingest_run_id = p.ingest_run
ORDER BY p.moiety_lo, p.moiety_hi, s.severity_rank, p.upstream_key;

COMMENT ON VIEW drugref.drugcentral_ddi_pair IS
    'DrugCentral''s NDF-RT interactions as ONE row per unordered moiety pair, '
    'carrying drugref''s derived grade beside the upstream band it came from. '
    'CANDIDATE TIER: the 2023 release does not refresh and nothing here is a '
    'drugref judgement -- the grade is ddi_source_severity''s reading of VA''s '
    'own band, and a curated ruling overrides it. Rows whose endpoint did not '
    'resolve are ABSENT rather than dropped: they are still in '
    'drugcentral_ddi_assertion and are published as questions.';
COMMENT ON COLUMN drugref.drugcentral_ddi_pair.upstream_severity_label IS
    'The authority''s own word, kept beside the derived grade so the mapping can '
    'be checked and disagreed with without re-reading a 1.4 GB dump.';

-- ============================================================================
-- 5. exact_ddi_pair -- the read path exact pairs have never had
-- ============================================================================
-- drugref has held EXACT drug-drug pairs since db/014 and no view has ever
-- returned them: ddi_candidate_pair expands class_contraindication only, and
-- nothing else reads moiety_contraindication at all. A second source of exact
-- pairs makes that hole load-bearing, so this view closes it.
--
-- WHY NOT AN ARM ON ddi_candidate_pair, which is the shape db/033 chose for the
-- two grains: db/034 then MEASURED that arm costing 3.6x with the new grain
-- EMPTY -- a structural cost paid by every existing consumer on every query, for
-- content most of them do not have. And that view's columns are
-- class-expansion-shaped (via_class, member_class, is_direct), all meaningless at
-- moiety grain, so unioning would mean 7,501 rows of NULL in three columns. This
-- view is ADDITIVE: no existing query changes.
--
-- UNION ALL, not UNION: fewer rows is the harm direction for a contraindication,
-- so a pair asserted by two authorities appears twice rather than being folded to
-- whichever one sorted first. Which authority a consumer should believe is issues
-- 97/106's question and is deliberately not answered here.
CREATE OR REPLACE VIEW drugref.exact_ddi_pair AS
-- Arm 1: MED-RT's CI_ChemClass moiety arm (db/014). DIRECTIONAL -- MED-RT states
-- which drug the assertion is ABOUT -- so subject/object stay populated, while
-- moiety_lo/moiety_hi give the unordered LOOKUP key both arms share. It asserts
-- no severity, hence the NULLs.
SELECT least(mc.subject_moiety_uuid, mc.object_moiety_uuid)    AS moiety_lo,
       greatest(mc.subject_moiety_uuid, mc.object_moiety_uuid) AS moiety_hi,
       mc.subject_moiety_uuid  AS subject_moiety,
       mc.object_moiety_uuid   AS object_moiety,
       mc.source               AS candidate_source,
       mc.relationship,
       NULL::text              AS severity,
       NULL::smallint          AS severity_rank,
       NULL::text              AS upstream_severity_label,
       r.upstream_release,
       r.finished_at           AS ingested_at
FROM   drugref.moiety_contraindication mc
JOIN   drugref.ingest_run r ON r.ingest_run_id = mc.ingest_run
UNION ALL
-- Arm 2: DrugCentral's graded unordered pairs. It names no subject, so those two
-- columns are NULL -- a fact about the source, not a missing value. It names no
-- axis either: `relationship` is MED-RT's typed predicate vocabulary and VA's
-- assertion is simply "these two interact".
SELECT p.moiety_lo,
       p.moiety_hi,
       NULL::uuid              AS subject_moiety,
       NULL::uuid              AS object_moiety,
       p.candidate_source,
       NULL::text              AS relationship,
       p.severity,
       p.severity_rank,
       p.upstream_severity_label,
       p.upstream_release,
       p.ingested_at
FROM   drugref.drugcentral_ddi_pair p;

COMMENT ON VIEW drugref.exact_ddi_pair IS
    'Every EXACT drug-drug pair some upstream authority asserts, whatever its '
    'grain -- the read path moiety_contraindication has lacked since db/014. '
    'KEYED UNORDERED (moiety_lo, moiety_hi), because "am I about to co-prescribe '
    'these two?" is an unordered question; a source that DOES assert a direction '
    'keeps it in subject_moiety/object_moiety. CANDIDATE TIER, and DELIBERATELY '
    'NOT A SUPERSET OF ddi_candidate_pair: that view expands CLASS rules and this '
    'one does not, so a consumer wanting everything reads both. severity is NULL '
    'wherever the authority states none.';

-- ============================================================================
-- 6. gap_unresolved_ddi_endpoint, and the eighteenth question kind
-- ============================================================================
-- NO TABLE OF ITS OWN, unlike db/031's ingest_unresolved_onc_endpoint. That table
-- was needed because _GAP_SOURCES derives every kind FROM A VIEW and an ONC
-- endpoint resolving to nothing was in no table at all. Here the assertion table
-- already holds every row, resolved or not, so a view over it is the whole job.
--
-- GRAIN: one folded endpoint NAME, not one row. A curator resolves a name; 37
-- rows over 10 names is 10 questions. The fold is lower(trim(...)), which is
-- drugcentral_resolve.fold_name's rule -- restated here because question_uuid is
-- IMMORTAL and externally cited, so two spellings of one endpoint must never mint
-- two questions that can then be answered differently.
--
-- FILTERED ON A NULL uuid, NEVER ON THE ROUTE VOCABULARY. The routes are
-- descriptive; filtering on them would put that list in a second place, which is
-- the defect db/006 exists to remove -- and this view would then need widening
-- every time a route is added.
CREATE OR REPLACE VIEW drugref.gap_unresolved_ddi_endpoint AS
SELECT e.source,
       e.endpoint_name,
       count(*)                AS row_count,
       max(r.upstream_release) AS upstream_release
FROM  (SELECT a.source, a.ingest_run,
              lower(btrim(a.endpoint_1_name)) AS endpoint_name
         FROM drugref.drugcentral_ddi_assertion a
        WHERE a.moiety_1_uuid IS NULL
        UNION ALL
       SELECT a.source, a.ingest_run,
              lower(btrim(a.endpoint_2_name)) AS endpoint_name
         FROM drugref.drugcentral_ddi_assertion a
        WHERE a.moiety_2_uuid IS NULL) e
JOIN  drugref.ingest_run r ON r.ingest_run_id = e.ingest_run
      -- A blank endpoint is not a question anyone can answer, and the resolver
      -- already refuses to look one up (an empty structural key would otherwise
      -- collapse every keyless substance onto one moiety).
WHERE e.endpoint_name <> ''
GROUP BY e.source, e.endpoint_name;

COMMENT ON VIEW drugref.gap_unresolved_ddi_endpoint IS
    'Endpoint names DrugCentral resolves to a structure and drugref cannot key. '
    'ONE ROW PER FOLDED NAME, because a curator resolves a name rather than a '
    'row. Measured 2026-08-23: 37 rows over 10 names, every one on route '
    '''unresolved'' -- DrugCentral holds an InChIKey or a CAS number that no live '
    'identity_claim carries. They are REGISTRY-COVERAGE work, not a synonym list: '
    '''phytomenadione'' is the INN for phytonadione and ''atracurium'' the base of '
    'the besylate drugref already holds, so an answer could change something, '
    'which is db/012''s test for whether the review gate may ask at all. The '
    'question retires by itself when the claim lands.';

-- The eighteenth question kind. Guarded on the constraint's TEXT rather than its
-- name, so a replay against an already-widened database skips the drop/add
-- entirely instead of rescanning -- the idiom db/016, db/019, db/022, db/028,
-- db/029, db/031 and db/039 all reuse.
DO $$
BEGIN
    IF NOT EXISTS (SELECT 1 FROM pg_constraint
                   WHERE  conname  = 'open_question_gap_kind'
                   AND    conrelid = 'drugref.open_question'::regclass
                   AND    pg_get_constraintdef(oid) LIKE '%unresolved_ddi_endpoint%') THEN
        ALTER TABLE drugref.open_question DROP CONSTRAINT IF EXISTS open_question_gap_kind;
        ALTER TABLE drugref.open_question ADD CONSTRAINT open_question_gap_kind
            CHECK (gap_kind IN (
                -- COPIED VERBATIM from the live catalog, then extended by one.
                -- Retyping this list from memory would silently drop a kind and
                -- orphan every question already minted under it -- and db/039
                -- found the live catalog holding SIXTEEN where its own plan
                -- expected fifteen, because db/035 had landed in between. Here
                -- the live catalog already held SEVENTEEN, one more than this
                -- brief's own comments assumed, for the identical reason.
                'unpopulated_contraindication', 'unclassified_moiety',
                'unmatched_ingredient', 'unreviewed_expansion_root',
                'unresolved_ci_object', 'dead_by_expansion_policy',
                'condition_without_indication', 'uncurated_additive_effect',
                'uncurated_threshold', 'ineffective_contribution',
                'ungraded_contribution', 'unruled_composition_activity',
                'uncurated_condition_contradiction', 'uncurated_interaction_rule',
                'unresolved_onc_endpoint', 'uncurated_class_interaction_rule',
                'fda_cyp_unadjudicated',
                'unresolved_ddi_endpoint'));
    END IF;
END $$;
